As amyloid-targeting therapies for Alzheimer’s fail, where might success lie? (NYSE:LLY)

tupungato/iStock via Getty Images Mid- and late-stage data readouts over the last few years for Alzheimer’s therapies have had a similar theme: Failure. Almost all these candidates have one thing in common: They target reducing beta-amyloid plaque in the brain that is thought to play a role in the memory-robbing disease. However, the amyloid-targeting theme … Read more

Novartis to invest $250M for new therapies to fight neglected tropical diseases, malaria

Robert Way/iStock Editorial via Getty Images Novartis (NYSE:NVS) said it is committing $250M over five years to advance research and development (R&D) of new treatments to fight against neglected tropical diseases and malaria. The Swiss pharma giant made the June 23 announcement in conjunction with the Kigali Summit on Malaria and NTDs alongside the 26th … Read more

COVID therapies and vaccines propel rise in spending on medicines in 2021 (NYSE:PFE)

Petmal/iStock via Getty Images Demand for COVID-19 vaccines and therapies helped contribute to a 12% increase in spending on medicines in the U.S. in 2021, according to the IQVIA Institute for Human Data Science. U.S. spending on medicines reached $407B last year, with COVID-19 vaccines and therapeutics adding $29B to that amount. IQVIA’s (IQV) report, … Read more